The FDA has granted traditional approval to Darzalex Faspro in combination with bortezomib, cyclophosphamide, and dexamethasone for the treatment of adults with newly diagnosed light chain amyloidosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback